Axcelis Technologies, Inc. (ACLS) Reports In-Line Q2 Loss

Axcelis Technologies, Inc. (NASDAQ: ACLS) reported Q2 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $41.2 million versus the consensus estimate of $40.75 million.

For earnings history and earnings-related data on Axcelis Technologies, Inc. (ACLS) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c